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Abstract 
Polyubiquitinated proteins tagged with multi-ubiquitin chains are substrates preferred by the 26 S proteasome (a ubiquitin/ATP-dependent 
proteolytic complex). Here, we developed a simple method for the efficient preparation of polyubiquitinated proteins which are degraded by the 26 S 
proteasome in an ATP-dependent manner. Our efficient method enabled us to produce ten monoclonal antibodies that recognized the multi-ubiquitin 
chains of the polyubiquitinated proteins, but not free ubiquitin or the protein moieties. Eight of the antibodies recognized only the multi-ubiquitin 
chains of the polyubiquitinated proteins, while the other two antibodies cross-reacted with mono-ubiquitin and methyl-ubiquitin, both of which are 
linked to proteins via an isopeptide bond, as well as with the multi-ubiquitin chains. Thus these antibodies are novel and useful tools for the 
identification and quantification of polyubiquitinated proteins in various cells and tissues under physiological and pathological conditions. 
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1. Introduction 
Ubiquitin (Ub), a polypeptide of 76 amino acid resi- 
dues, is the highly conserved and widely distributed pro- 
tein in eukaryotic cells [ 1 J. It has been proposed that this 
protein plays important roles in various biological proc- 
esses such as the regulation of cell cycles [2-4], DNA 
replication [5], DNA repair [6], stress response [7,8], 
apoptosis [9], signal transduction [lo-121, biogenesis of 
ribosome [ 13,141, nucleosome [151, peroxisome [ 161 and 
myofibril [17]. In these processes, the Ub functions as 
both a signal for protein degradation and as a chaperone 
promoting the formation of organelles. It has also been 
reported that Ub-protein conjugates accumulate in the 
brain under certain pathological conditions, for exam- 
ple, Alzheimer’s disease [18,191 and Parkinson’s disease 
[20], and also ischemic damage [21,22]. 
Several previous reports have suggested that intracel- 
lular abnormal and short-lived proteins are degraded 
through the Ub-dependent proteolytic pathway (for re- 
views, see [23-261). In the Ub-dependent pathway, a tar- 
get protein is tagged with poly-Ub molecules (referred to 
as the multi-Ub chain in this report) via isopeptide bonds 
which are formed between the carboxyl-termini of the 
Ub molecules and either of the &-amino groups of the 
lysine residues in the protein or in the Ub molecules 
themselves [1,23,24]. This reaction is catalyzed by se- 
quential actions of El (Ub-activating enzyme), E2 (Ub- 
conjugating enzyme), and occasionally E3 (N-recognin) 
*Corresponding author. Fax: (81) (1 I) 706-4900. 
Abbreviations: Ub, ubiquitin; PBS, phosphate-buffered saline; PAGE, 
polyacrylamide gel electrophoresis; DTT, dithiothreitol; IgG, immu- 
noglobulin G; ELISA, enzyme-linked immuno-sorbent assay. 
with the aid of energy derived from ATP hydrolysis. 
Thus formed, polyubiquitinated proteins tagged with the 
multi-Ub chains (poly-Ub-protein conjugates) are des- 
tined to be degraded by the 26 S proteasome, a Ub/ATP- 
dependent proteinase complex, in an ATP-dependent 
manner [23-261. 
While the poly-Ub-protein conjugates are substrates 
preferred by the 26 S proteasome [23-291, the previous 
use of the partially purified preparation of the above 
Ub-ligating system, which could be contaminated by the 
26 S proteasome and/or isopeptidase, did not lead to the 
production of a large amount of the poly-Ubprotein 
conjugate. Recently, Tamura et al. [30] improved the 
previous methods of Hough et al. [29] and Hershko et al. 
[31] for the preparation of the poly-Ub-protein conju- 
gates. We have slightly modified the method of Tamura 
et al. [30] and performed ultracentrifugation as an addi- 
tional purification procedure in order to remove the pos- 
sible contaminating 26 S proteasome and/or isopepti- 
dase. Our modified method permitted us to prepare the 
poly-Ub-protein conjugates more efficiently. The prepa- 
ration of poly-Ub-protein conjugates appeared very sta- 
ble during a prolonged incubation without proteasome, 
and was rapidly degraded in an ATP-dependent manner 
by adding the 26 S proteasome. 
The improvement in the preparation of a large amount 
of the poly-Ub-protein conjugate using lysozyme ena- 
bled us to produce 10 monoclonal antibodies that recog- 
nized the poly-Ub-lysozyme conjugates but not free Ub 
or lysozyme. Two of the established monoclonal anti- 
bodies were found to recognize mono-Ub and methyl- 
Ub linked via isopeptide bonds to lysozyme in addition 
to the multi-Ub chains of the poly-Ub-lysozyme conju- 
gates, while the other eight antibodies were highly spe- 
cific to the multi-Ub chains but not the mono- or methyl- 
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Ub linked to lysozyme. To our knowledge, this is the first 
report on such specific monoclonal antibodies directed 
against the poly-U&protein conjugates. These antibod- 
ies are expected to be useful tools for identifying and 
quantifying the poly-Ub-protein conjugates and also for 
discriminating the multi-Ub chains from the protein- 
linked mono-Ub and free Ub in various cells and tissues 
under certain physiological and pathological conditions. 
2. Materials and methods 
2. I. Materials 
Bovine Ub, ATP, yeast inorganic pyrophosphatase, rabbit creatine 
phosphokinase (Type I), phosphocreatine and molecular mass standard 
proteins were purchased from Sigma Chemical Co. Affi-Gel 10 was 
obtained from- Bio-Rad Laboratories. Bovine chymotrypsinogen A, 
chicken egg white lvsozvme and DEAE-cellulose (DE-32) were rmr- 
chased from Worthington Biochemical Corp., Seikagaku ‘Kogyo’Co. 
and Whatman, respectively. [“‘I]NaI was obtained from New England 
Nuclear. Rabbit polyclonal antibody raised against chicken lysozyme 
was prepared by Dr. F. Arisaka in our laboratory. 
2.2. Preparation of (/b-ligating enzymes (El, E2 and E3) 
El, E2 and E3 were prepared from the reticulocyte lysate according 
to the methods described by Tamura et al. 1301 and Hershko et al. 1311 
with slight modifications. The reticulocyte lysate was ultracentrifuged 
at 100,000 x g for 6 h in order to precipitate the 26 S proteasome. The 
resulting supernatant was successively subjected to DEAE-cellulose 
chromatography, concentration using an Amicon PM-IO membrane 
and chromatography on UbAffi-Gel 10 (prepared according to the 
manufacture’s protocol). A mixture of El and E2, and E3, separately 
isolated from the UbAffi-Gel 10 column, were dialyzed against 50 mM 
Tris-HCI (pH 7.5), I mM DTT, 0.2 mM ATP and 20% glycerol, concen- 
trated by ultrafiltration using PM-10 membrane and then frozen in 
liquid N,. Protein concentration was determined by the method of 
Bradford [32]. 
2.3. Preparation of poly-U~[‘2sI]lysozyme and 
methyl- Ub-[‘zsIJlysozyme 
[‘251]Lysozyme was prepared with [‘*‘I]NaI and chloramine-T essen- 
tially according to the standard method [33]. Methyl-Ub was prepared 
according to the method of Hershko and Heller [34]. Poly-Ubprotein 
conjugates were prepared as described by Tamura et al. [30] with slight 
modifications. Usually, the reaction mixture contained 100 mM Tris- 
HCI (pH 9.0), 5 mM MgCl,, 1 mM DTT, 2 mM ATP, 20 &ml of 
heat-denatured [‘251]lysoz$ne (lOO”C, 20 min), 6 mg/ml of Ub (or 
0.1 me/ml of methvl-Ub). 0.15 ma/ml of El/E2 mixture. 0.45 mp/ml of 
E3, 22 unit/ml of inorganic py;ophosphatase, 10 fiirnl of cyeatine 
phosphokinase and 10 mM phosphocreatine. This mixture was incu- 
bated at 37°C for 1-3 h, and the amounts of poly-Ub and methyl- 
Ublysozymes were quantified by SDS-PAGE followed by autoradi- 
ography. 
2.4. Degradation of poly-U&protein conjugates 
ATP-dependent degradation of poly-Ubprotein conjugates by the 
26 S proteasome was measured as follows; a reaction mixture (200 PI), 
which contained 50 mM Tris-HCI (pH 7.8), 10 mM MgCI,, 2 mM ATP, 
1 mM DTT, 0.2 pg of [‘2SI]proteins (18,000 cpm) tagged with multi-Ub 
chains and 3 lug of the 26 S proteasome purified from rabbit skeletal 
muscle as described previously [35], was incubated at 37°C for 2 h, and 
the reaction was stopped by the addition of 25 ~1 of cold 10% bovine 
serum albumin and 600 ~1 of cold 10% trichloroacetic acid. After 
standing for more than 10 min on ice, the acid-soluble radioactivity was 
measured by a y-counter. 
The ATP-independent degradation was measured as described above 
except for 5 mM EDTA instead of IO mM MgCl, and 2 mM ATP. 
2.5. Electrophoreses and Western blot analysis 
SDS-PAGE (12.5%) was carried out according to the method of 
Laemmli [36]. After electrophoresis, proteins were stained with 
Coomassie brilliant blue R-250 and dried in vacua followed by autora- 
diography using Fiji X-ray film New RX. Western blot analysis was 
performed by the method of Towbin et al. 1371 with peroxidase-conju- 
gated anti-mouse or anti-rabbit IgG as a secondary antibody and both 
H,O, and 3,3’-diaminobenzidine as peroxidase substrates. 
2.6. Immunization and screening of hybridoma cells 
A crude preparation of the poly-Ublysozyme, which contained ly- 
sozyme, free Ub, Ub-ligating system and the ATP-regenerating system, 
was used as an immunogen (50 fig of lysozyme/mouse) and the fusion 
of the spleen cells with myeloma cells was performed according to the 
standard polyethylene glycol method [38]. 
Antibody production was screened by the sandwich ELISA method 
as described below. Each well of ELISA plate (96-wells) was coated 
with 100 ~1 of anti-Ub polyclonal antibody (5 ,@ml PBS) which had 
been produced according to the method of Hads and Bright [39] and 
subsequently affinity-purified using the UbAffi-Gel 10 (prepared as 
described above). After washing with PBS and blocking with 200 ~1 of 
3% skim milk in PBS, a crude preparation of poly-Ublysozyme 
(100 ~1) diluted with PBS (300-fold) was added to each well, and the 
plate was incubated at room temperature for 2 h to allow the poly- 
Ublysozyme to be adsorbed on the anti-Ub polyclonal antibody. After 
the wells were extensively washed with PBS, a culture medium of hy- 
bridoma cells was added to each well and the plate was incubated at 
room temperature for 2 h to allow antibodies in the culture medium to 
be adsorbed on the poly-Ublysozyme bound to the anti-Ub polyclonal 
antibody. After extensive washing with PBS, biotin-conjugated anti- 
mouse IgG (Vector) and then avidin-biotinated peroxidase complex 
were added to each well and the plate was incubated at room tempera- 
ture for 30 min. Color was developed using 0.02% H,O, and 0.2 mg/ml 
2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) as peroxidase sub- 
strates. Positive culture media of hybridoma cells thus tested were 
further subjected to negative screening by ELISA using either free Ub 
(5Opg/ml) or the reaction mixture for the Ub-ligation which lacked only 
Ub, in place of the crude poly-Ublysozyme preparation. Hybridoma 
cells producing the antibodies that were cross-reactive with only the 
poly-Ub-lysozyme but not with free Ub or the above negative control 
reaction mixture were cloned by the method of limiting dilution, and 
ten antibody-producing clones were established. 
3. Results 
3.1. Preparation and characterization ofpoly-Ub-protein 
conjugates 
Ub-ligating enzymes, El, E2 and E3, were isolated 
from rabbit reticulocyte lysate, as described by Tamura 
et al. [30] with slight modifications, by a procedure 
including ultracentrifugation and chromatography on 
DEAE-cellulose and Ub-Affi-Gel 10 columns. Approxi- 
mately 5 mg each of a fraction containing El and E2, and 
of an E3 fraction was obtained from 300 ml of reticulo- 
cyte lysate. 
The Ub-ligating reaction was mediated by our prepa- 
rations of El, E2 and E3 using heat-denatured lysozyme 
and Ub as substrates, one of which was labeled with ‘251. 
The extent of the reaction was analyzed by SDS-PAGE 
(12.5% gel) followed by autoradiography (Fig. 1). Strong 
bands of molecular masses higher than 66 kDa in both 
cases of [‘251]lysozyme and [‘251]Ub were detected within 
a period of 30-min reaction, indicating that these newly- 
formed bands correspond to the poly-Ublysozyme con- 
jugates. Within 60 min, approximately 70% of the total 
[‘251]lysozyme was found to be polyubiquitinated by 
quantitative analysis using Fuji Bioimaging Analyzer 
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Fig. I. Polyubiquitination of lysozyme with El, E2 and E3 using either 
radiolodinated lysozyme or radioiodinated Ub. Poly-U~[‘2’I]lysozymme 
conjugates were prepared as described in section 2. PoI~-[“~I]L~~- 
lysoryme conjugates were prepared by the fame method except for 0.1 
mg/ml of [“‘IJUb and 3.Y mg/ml of cold Ub instead of 6 mg/ml of Ub. 
The reaction was carried out for 0, 30 and 60 min and then stopped by 
the addition of a sample buffer containing SDS. A portion (30 ~1) of 
the reaction mixture was subjected to SDS-PAGE and analyzed by 
autoradiography. Amounts of radioactivities of the poly-Ub-[‘*51]ly 
sozyme conjugates were quantified by Fuji Bio-imaging Analyzer BAS 
2000. Molecular mass standards used were bovine serum albumin 
(66 kDa), chicken ovalbumm (45 kDa), bovine chymotrypsinogen A
(25 kDa) and sperm whale myoglobin (18 kDa). The migration points 
of lysozyme and Ub are indicated by arrows. 
Bas 2000. The poly-Ub-lysozyme conjugates thus 
formed remained stable during a prolonged incubation 
(at least 3 h). Since the poly-U&protein conjugates are 
known to be substrates which are highly susceptible to 
the 26 S proteasome, we next examined the susceptibility 
of our preparation of poly-Ut+[‘251]lysozyme conjugates 
to the 26 S proteasome purified from rabbit skeletal mus- 
cle. As shown in Fig. 2, poly-Ub[‘251]lysozyme conju- 
gates, detected as main bands of about 200 kDa on SDS- 
PAGE, were rapidly degraded by the 26 S proteasome in 
an ATP-dependent manner. 
In order to elucidate whether proteins other than ly- 
sozyme can also be polyubiquitinated and the polyubiq- 
uitinated proteins can serve as substrates for the 26 S 
proteasome, polyubiquitinations of oxidized [1251]ribo- 
nuclease A and [‘2SI]a-lactalbumin were performed. It 
was found that our preparation of Ub ligation system 
(El, E2 and E3) was capable of catalyzing polyubiquiti- 
nation of either protein (see autoradiography in Fig. 4). 
In addition, these poly-Ubprotein conjugates were de- 
graded by- the 26 S proteasome in an ATP-dependent 
fashion as efficiently as the poly-Ublysozyme conju- 
gates (Table 1). 
All of these results indicate that our preparations of 
El, E2 and E3 are very useful for efficient preparation 
of poly-Ub-protein conjugates. These results enabled us 
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to produce monoclonal antibodies raised against the 
poly-Ublysozyme conjugates. 
3.2. Production and characterization qf monoclonul 
antibodies pecific to poly- U&protein conjugates 
Eight hybridoma clones called FKI, 169H, lE, 31A, 
12H, 99F, 9A and 58D were established, which produced 
monoclonal antibody cross-reactive only with the poly- 
Ublysozyme conjugates but not with free Ub, the plain 
lysozyme or mono-Ub linked to the lysozyme, as re- 
vealed by Western blotting (Fig. 3a in the cases of FKl 
and lE, see Table 2). Free Ub and mono-Ub linked to 
the lysozyme were detectable by Western blotting with 
anti-Ub polyclonal antibody, while the lysozyme mole- 
cule was detected by blotting with anti-lysozyme polyclo- 
nal antibody. We also established two hybridoma clones 
called FK2 and 135C, both of which produced monoclo- 
nal antibody specific to the mono-Ub linked to lysozyme 
as well as to the poly-Ubprotein conjugates, but not free 
Ub or free lysozyme (Fig. 3a in the case of FK2, see 
Table 2). 
In order to prove that the latter two antibodies (FKZ 
and 13X) but not the former eight ones recognized the 
mono-Ub linked to lysozyme, we prepared the methyl- 
Ub-[‘2SI]lysozyme using methyl-Ub in place of unmodi- 
fied Ub and tested the cross-reactivity of each antibody 
Poly-Ub[t= I ]- Poly-uL[ ‘25 I ]-lysozyme 
lysozyme 
1 
+ 26s Proteasome 
+ATP -ATP 
10 30 60 IO 30 60 time (min) 
29-b 
Fmnl - 
Fig. 2. Degradation of poly-Ut+[‘*sIJlysozyme conjugates by the 26s 
proteasome. The enzymatic reaction with 6 pg of the purified 265 
proteasome from rabbit skeletal muscle in the presence or absence of 
2 mM ATP was carried out for the indicated tune using 0.2 pg of 
poly-Ub[“‘]lysozyme conjugates as substrate under the conditions 
described in secton 2. The reaction was terminated by adding the SDS 
sample buffer. The extent of degradation was monitored by SDS- 
PAGE followed by autoradiography. Molecular mass standards used 
were rabbit myosin light chain (205 kDa), rabbit phosphorylase h (97 
kDa), bovine serum albumin (66 kDa), chicken ovalbumin (45 kDa) 
and bovine carbonic anhydrase (29 kDa). 
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Table 1 
Degradations of [“51]proteins and poly-Ub-[‘251]protein conjugates by 
the 26 S proteasome in the presence or absence of ATP 
[‘*‘]Protein Degradation (%) Ratio 
+ ATP - ATP (+ ATPI 
- ATP) 
Heat-denatured lysozyme - Ub” 11.9 18.9 0.6 
+ Ubb 54.8 23.3 2.4 
Ribonuclease A -Ub” 27.8 28.1 I.0 
+ Ubb 57.6 11.5 5.0 
a-Lactalbumin -Ub” 15.1 12.8 1.2 
+ Ubb 64.8 28.6 2.3 
[‘2SI]Proteins (0.2pg, about 20,000 cpm) or poly-Ub[‘251]protein conju- 
gates (0.2 pg, about 20,000 cpm) were hydrolyzed by the purified 26 S 
proteasome (6 pg) in the presence or absence of 2 mM ATP. 
d Original [‘Z51]protein. 
‘Poly-Ub-protein conjugates. 
with this modified protein by Western blotting (Table 2). 
The representative results with FKl, 1E and FK2 anti- 
bodies are shown in Fig. 3b. The results actually showed 
that FK2 antibody, as well as 135C antibody, reacted 
with the methyl-Ublysozyme and also with the poly- 
Ub-lysozyme conjugates. In contrast, FKl and 1 E anti- 
bodies did not react with the methyl-Ublysozyme. The 
same was true for other antibodies of 31A, 12H, 99F, 
169H, 9A and 58D. These results indicate that our ten 
antibodies can be classified into at least two groups. 
Furthermore, close investigation of band patterns on 
Western blots suggests that the former eight antibodies 
may be further divided into two subgroups (see Fig. 3a): 
Table 2 
Cross-reactivities and classes of monoclonal antibodies raised against 
poly-Ublysozyme conjugates 
Clone Subclass Cross-reactivity 
(light chain) 
Free Ub Poly-Ub” Methyl- Ubb 
WB’ ELBA WB’ ELISA WB’ 
FKI IgM (K) - - +++d +++ 
169H IgG2b (K) - - ++d ++ 
1E IgM (IC) ~ ~ +* ii+ - 
31A IgGl (K) - -. +“ ++ 
12H IgGl (K) ~ +d + 
99F IgGl (IC) +” +++ - 
9A IgM (K) - - +d ++ ~ 
58D IgM (K) - - kd ++ 
FK2 IgGl (K) - - +++ +++ +++ 
135c IgM (K) - - +++ +++ +++ 
a Poly-Ublysozyme conjugates. 
’ Methyl-Ublysozyme. 
‘Western blotting. 
“Note that band patterns on Western blots are different between a 
group of FKI and 169 H and a group of lE, 3lA, 12H, 99H, 9A and 
58D. 
one is an FKl type (FKl and 169H) and the other is a 
1E type (IE, 31A, 12H, 99F, 9A and 58D). 
Almost the same results by Western blot analysis were 
obtained with polyubiquitinated oxidized [‘251]ribonu- 
clease A (Fig. 4a) and polyubiquitinated [‘251]ol-lactalbu- 
min (Fig. 4b). These results including those with 
polyubiquitinated [1251]lysozyme indicate that our mono- 
clonal antibodies never recognize the substrate protein 
moiety of the poly-I-lb-protein conjugates and do recog- 
nize the Ub moiety (either the mono-Ub form or the 
multi-Ub chain, dependent on the antibodies) of the con- 
jugates. So far, such specific monoclonal antibodies have 
not yet been produced. Thus, our monoclonal antibodies 
are very useful for identification and quantification of 
the multi-Ub chains of poly-Ub-protein conjugates and 
also for discrimination between the multi-Ub chain and 
the mono-Ub linked to proteins ubiquitinated. 
4. Discussion 
We succeeded in developing a modified method to 
prepare large amounts of poly-Ub-protein conjugates 
efficiently [30]. Ultracentrifugation (100,000 x g, 6 h) 
utilized as a new procedure in this study was found to be 
an effective step for removing the 26 S proteasome and 
its associating isopeptidase, contamination of which 
could make the prepared poly-Ub-protein conjugates 
unstable through degradation or de-ubiquitination. 
Thus, this step appeared essential for efficient prepara- 
tion of the poly-Ub-protein conjugates. 
It has been reported that a crude preparation of the 
poly-Ub-[‘251]lysozyme conjugates is not suitable for a 
substrate of the 26 S proteasome due to their insuscepti- 
bility [30]. In our experiments, however, our preparation 
of the poly-Ub-[‘251]lysozyme conjugates was found to 
be a very useful substrate for assay of Ub-conjugate 
degrading activity of the 26 S proteasome: the poly-Ub 
[‘251]lysozyme conjugates prepared by our method were 
reasonably stable in the absence of the 26 S proteasome 
but were very rapidly degraded by the enzyme in an 
ATP-dependent manner. These properties of our poly- 
Ubprotein conjugates give strong support to our prepa- 
ration being a natural (i.e. 26 S proteasome-susceptible) 
form of poly-Ub-protein conjugates. 
Using such natural poly-Ub-lysozyme conjugates as 
immunogen, we established ten hybridoma clones pro- 
ducing monoclonal antibodies that recognized the poly- 
Ub-protein conjugates. We found that there are three 
different band patterns detected by our ten monoclonal 
antibodies on Western blots of both the crude prepara- 
tions of the poly-Ublysozyme conjugates and the 
methyl-Ub-lysozyme. One is reactive with both the poly- 
Ub-protein conjugates and the methyl-Ublysozyme, 
while the other two are reactive with only the poly-Ub 
protein conjugates. In the latter case there are two differ- 
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ent band patterns on the blots of the poly-L&protein 
conjugates. It can be imagined that the latter two groups 
of the antibodies recognize the molecular structure of the 
isopeptide bond formed between a carboxyl group of the 
C-terminal glycine residue of one Ub molecule and an 
E-NH, group of the lysine residue of the other Ub mole- 
cule. On the other hand, the former group could recog- 
nize the sequence around the isopeptide bond formed 
between the C-terminus of Ub and the lysine residue of 
lysozyme. These considerations imply there is a differ- 
ence in molecular structure of isopeptide bond formed 
between the Ub molecules themselves from that formed 
between the Ub molecule and the protein moiety ubiq- 
uitinated. Furthermore, different band patterns on West- 
ern blots between the latter two groups also implies the 
presence of different types of isopeptide bonds formed 
between the Ub molecules themselves. Such a situation 
would occur if an isopeptide bond could be formed be- 
tween the C-terminus of one Ub molecule and one of the 
Lys6, Lys”, LYS~~, LYS~~, LYS~~, LYS~~, or LYS~~ residue of 
the other Ub molecule. Further detailed studies are nec- 
essary for elucidation of the epitopes recognized by our 
monoclonal antibodies at a molecular level. 
Several immunocytochemical reports on the localiza- 
tion of Ub in the brain of neurodegenerative diseases 
have been presented (for review, see [40]), suggesting that 
ubiquitinated proteins accumulate under these pa- 
thological conditions. Since polyclonal antibody raised 
against Ub molecule was always used in these studies, the 
extent of polyubiquitination of putative target proteins 
cannot be assigned. On the other hand, Western blot 
analysis using the conventional anti-Ub polyclonal anti- 
body indicates that highly-polyubiquitinated proteins ac- 
cumulate in ischemic damage [21,22] or in response to 
heat shock [7]. Furthermore, it has been reported that the 
multi-Ub chains are linked via isopeptide bonds to the 
paired helical filaments in Alzheimer’s disease [18,19]. 
Even under certain physiological conditions, intracellu- 
lar regulatory proteins functioning in the progression of 
cell cycles have been reported to be polyubiquitinated at 
restricted points and then degraded by the 26 S pro- 
teasome [2-4], and the Ub molecule linked via peptide 
bond in a monoubiquitinated form or linked via isopep- 
tide bond in mono- or oligo-ubiquitinated form has been 
proposed to promote the biogenesis of organelles 
[13-171. These reported data indicate that the Ub-liga- 
tion reaction is a crucial event for cellular activities. Our 
monoclonal antibodies produced in this study can quan- 
tify the extent of polyubiquitination in the above circum- 
stances and their combinations can discriminate the 
states among polyubiquitination leading to the forma- 
tion of the multi-Ub chains, monoubiquitination and 
free Ub. Actually, in our experiments, we found that the 
amount of polyubiquitinated proteins in plasma was 
measurable by sandwich ELBA using our monoclonal 
antibodies. We also found that Western blot analysis of 
the Alzheimer’s paired helical filaments using our anti- 
bodies gave different patterns among the monoclonal 
antibodies, and also between our antibodies and the con- 
ventional anti-Ub antibody (to be published). Thus, we 
consider the monoclonal antibodies produced in this 
study to be useful tools for the analysis of the Ub-ligation 
system in various cellular events. 
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